首页 馆藏资源 舆情信息 标准服务 科研活动 关于我们
现行 ASTM F3223-17
到馆提醒
收藏跟踪
购买正版
Standard Guide for Characterization and Assessment of Tissue Engineered Medical Products (TEMPs) for Knee Meniscus Surgical Repair and/or Reconstruction 用于膝盖半月板外科修复和/或重建的组织工程医疗产品(TEMP)的表征和评估标准指南
发布日期: 2017-03-01
1.1 本指南旨在为参与生产、交付和监管组织工程医疗产品(TEMP)和用于膝半月板手术修复、置换和/或重建的其他组织的个人和组织提供资源。 1.2 本标准并非旨在解决与其使用相关的所有安全问题(如有)。本标准的用户有责任在使用前制定适当的安全和健康实践,并确定监管限制的适用性。 1.3 本国际标准是根据世界贸易组织技术性贸易壁垒(TBT)委员会发布的《关于制定国际标准、指南和建议的原则的决定》中确立的国际公认标准化原则制定的。 ====意义和用途====== 5.1 膝半月板损伤是最常见的骨科问题之一。半月板损伤包括急性撕裂(如运动损伤)、慢性退行性撕裂、挤压/半脱位和/或作为膝盖老化过程的一部分或多次半月板手术的结果而发生的退行性功能障碍。 膝关节镜下半月板部分切除术(半月板部分切除术)是最常见的矫形手术。 5.2 由于半月板软骨保护作用的丧失,年轻人半月板完全或接近完全切除与早期膝骨关节炎风险增加有关。外侧半月板损伤往往比内侧损伤更严重。建议个体进行半月板修复、增强、移植和/或重建,以恢复半月板的软骨保护作用,缓解疼痛,并预防退行性膝骨关节炎。 TEMP在提高半月板修复和/或重建手术效果方面的潜力已得到认可。 5.3 膝关节和颞下颌关节(TMJ)是具有半月板结构的关节。 5.4 TEMP可以通过改善植入部位的生物修复、在缺损部位提供机械功能或通过这些机制的组合来提高手术效果。 5.5 改善手术结果可能包括改善与术前相比的功能- 手术条件,缩短术后恢复时间,缓解疼痛,恢复正常日常活动,鼓励组织生长到缺损部位,恢复半月板的机械功能,延缓骨关节炎的进展,或两者的任何组合。
1.1 This guide is intended as a resource for individuals and organizations involved in the production, delivery, and regulation of tissue engineered medical products (TEMPs) and other tissues intended for use in the surgical repair, replacement, and/or reconstruction of the knee meniscus. 1.2 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use. 1.3 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee. ====== Significance And Use ====== 5.1 Injuries to the knee meniscus are one of the most common orthopaedic problems. Meniscus injures include acute tears (such as occur in sports injuries), chronic degenerative tears, extrusion/subluxation, and/or degenerative dysfunction that occurs as part of the knee aging process or as a result of multiple meniscus surgeries. Knee arthroscopy for partial excision of the knee meniscus (partial meniscectomy) is the most commonly performed orthopaedic procedure. 5.2 Complete or near complete excision of the meniscus in a young individual is associated with an early increased risk of knee osteoarthritis due to the loss of the meniscus chondroprotective effects. Lateral meniscal injuries tend to be more severe than medial injuries. Meniscus repair, augmentation, transplantation, and/or reconstruction is recommended in individuals to restore the chondroprotective effect of the meniscus, relieve pain, and prevent degenerative knee osteoarthritis. The potential of TEMPs to enhance the outcome of the surgical meniscus repair and/or reconstruction has been recognized. 5.3 The knee joint and temporomandibular joint (TMJ) are examples of joints with meniscal structures. 5.4 TEMPS may be used with the intent of enhancing the surgical outcome by improving the biological repair at the site of implantation, by providing mechanical function at a defect site, or by a combination of these mechanisms. 5.5 Improving surgical outcome may include improving function relative to the pre-operative condition, shortening the recovery time after surgery, relieving pain, enabling return to normal daily activities, encouraging tissue growth into the defect site, restoring the mechanical function of the meniscus, delaying the progression of osteoarthritis, or any combination thereof.
分类信息
关联关系
研制信息
归口单位: F04.44
相似标准/计划/法规
现行
ASTM F3225-17(2022)
Standard Guide for Characterization and Assessment of Vascular Graft Tissue Engineered Medical Products (TEMPs)
血管移植组织工程医疗产品(TEMPs)的特性和评估标准指南
2022-09-01
现行
YY/T 1435-2016
组织工程医疗器械产品 水凝胶表征指南
Tissue engineering medical device products—Standard guide for characterization of hydrogels
2016-07-29
现行
ASTM F3510-21
Standard Guide for Characterizing Fiber-Based Constructs for Tissue-Engineered Medical Products
组织工程医疗产品用纤维结构特征的标准指南
2021-04-01
现行
ASTM F2027-16
Standard Guide for Characterization and Testing of Raw or Starting Materials for Tissue-Engineered Medical Products
组织工程医疗产品原料或原料的表征和检测标准指南
2016-10-01
现行
YY/T 1616-2018
组织工程医疗器械产品 生物材料支架的性能和测试指南
Tissue engineering medical device products—Standard guide for characterization and testing of biomaterial scaffolds
2018-11-07
现行
ASTM F2150-19
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Regenerative Medicine and Tissue-Engineered Medical Products
再生医学和组织工程医疗产品用生物材料支架的特性和试验的标准指南
2019-10-01
现行
ASTM F3274-21
Standard Guide for Testing and Characterization of Alginate Foam Scaffolds Used in Tissue-Engineered Medical Products (TEMPs)
组织工程医疗产品(TEMP)用海藻酸钠泡沫支架的试验和特性的标准指南
2021-05-15
现行
ASTM F2450-18
Standard Guide for Assessing Microstructure of Polymeric Scaffolds for Use in Tissue-Engineered Medical Products
组织工程医疗产品用聚合支架微观结构评定的标准指南
2018-11-15
现行
ASTM F3515-21
Standard Guide for Characterization and Testing of Porcine Fibrinogen as a Starting Material for Use in Biomedical and Tissue-Engineered Medical Product Applications
作为生物医学和组织工程医疗产品应用的起始材料的猪纤维蛋白原的特性和试验的标准指南
2021-08-01
现行
ASTM F2347-24
Standard Guide for Characterization and Testing of Hyaluronan as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications
用于生物医学和组织工程医疗产品应用的透明质酸作为起始材料的表征和测试的标准指南
2024-08-15
现行
ASTM F2064-17
Standard Guide for Characterization and Testing of Alginates as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications
用于生物医学和组织工程医疗产品应用的藻酸盐作为起始原料的表征和检测标准指南
2017-03-01
现行
ASTM F2103-18
Standard Guide for Characterization and Testing of Chitosan Salts as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Product Applications
作为生物医学和组织工程医疗产品应用的起始材料的壳聚糖盐的特性和试验的标准指南
2018-06-01
现行
ASTM F2212-20
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs)
组织工程医疗产品(TEMPs)用外科植入物和基质用I型胶原的特性的标准指南
2020-12-01
现行
YY/T 1575-2017
组织工程医疗器械产品 修复和替代骨组织植入物骨形成活性的体内评价指南
Tissue engineering medical device products—Standard guide for in vivo assessment of implantable devices intended to repair or regenerate bone defect
2017-08-18